Financial vitality of the pharma companies in India Dr. Gayathri R.1,*, Aravindh S.2, Dhivya S. L.2, Gowsalya R.2 1Faculty, School of Management, Sastra University, Thanjavur 2MBA Student, School of Management, Sastra University, Thanjavur *Corresponding Author E-mail: gayathri@mba.sastra.edu
Online published on 24 August, 2018. Abstract “Staying fit” is new mantra of the present generation and the status of healthcare of a country are reflected in the human development index. Changing lifestyles are causal to increased expenses in health care. Insurance and pharma companies are an important constituent of health care and also contribute to the growth of employment opportunities and Gross domestic product (GDP). The article discusses the growth of the Indian pharmaceutical industry in the recent years. It enlightens the financial soundness of the Indian pharmaceutical companies through various financial ratios. It also explains the proposals undertaken by the government to augment the pharmaceutical industry amidst the challenges it faces regarding patents, pricing etc. The article concludes that the pharmaceutical companies need to align with the government initiatives for achieving Vision 2020. Top Keywords Pharmaceutical industry, Generic drugs, Investments, Cost efficiency, Ratio analysis. Top |